{"entity":{"type":"insider","cik":"0001704186","url":"/insider/0001704186","json_url":"/insider/0001704186.json","name":"Gentile Kimberly","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":11,"first":"2017-11-02","last":"2020-10-09","span_basis":"filed_date"},"name_variants":[{"name":"Gentile Kimberly","source":"filing","n_filings":11,"first_seen":"2017-11-02","last_seen":"2020-10-09"}],"transactions":[{"id":2849491,"accession":"0001562180-20-006335","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-006335","line_url":"/filing/0001562180-20-006335","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23500.0,"shares_display":"23,500","price_per_share":76.34391468085106,"price_display":"76.34","price_state":"stated","total_value":1794081.995,"total_display":"1,794,082.00","total_whole":"1,794,082","shares_owned_after":6097.0,"shares_owned_after_display":"6,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-09","scope":"insider","n_lines":3},{"id":2824329,"accession":"0001562180-20-004575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004575","line_url":"/filing/0001562180-20-004575#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":70.2029,"price_display":"70.20","price_state":"stated","total_value":1684869.6,"total_display":"1,684,869.60","total_whole":"1,684,870","shares_owned_after":3639.0,"shares_owned_after_display":"3,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-17","scope":"insider"},{"id":2128585,"accession":"0001562180-20-004603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004603","line_url":"/filing/0001562180-20-004603#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":70.2029,"price_display":"70.20","price_state":"stated","total_value":28081.16,"total_display":"28,081.16","total_whole":"28,081","shares_owned_after":3639.0,"shares_owned_after_display":"3,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-18","scope":"insider"},{"id":2712759,"accession":"0001562180-20-004419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004419","line_url":"/filing/0001562180-20-004419#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.0458,"price_display":"70.05","price_state":"stated","total_value":42027.48,"total_display":"42,027.48","total_whole":"42,027","shares_owned_after":3639.0,"shares_owned_after_display":"3,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":8173928,"accession":"0001689813-19-000096","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689813-19-000096","line_url":"/filing/0001689813-19-000096#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21065.0,"shares_display":"21,065","price_per_share":53.0361,"price_display":"53.04","price_state":"stated","total_value":1117205.4465,"total_display":"1,117,205.45","total_whole":"1,117,205","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-22","scope":"insider"},{"id":8173920,"accession":"0001689813-19-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689813-19-000096","line_url":"/filing/0001689813-19-000096#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (SVP, Clinical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3935.0,"shares_display":"3,935","price_per_share":53.028,"price_display":"53.03","price_state":"stated","total_value":208665.18,"total_display":"208,665.18","total_whole":"208,665","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":6726090,"accession":"0001209191-18-038584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-038584","line_url":"/filing/0001209191-18-038584#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":500250.0,"total_display":"500,250.00","total_whole":"500,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-19","scope":"insider"},{"id":6557049,"accession":"0001209191-18-016467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-016467","line_url":"/filing/0001209191-18-016467","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.8688,"price_display":"32.87","price_state":"stated","total_value":164344.0,"total_display":"164,344.00","total_whole":"164,344","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider","n_lines":2},{"id":6419180,"accession":"0001209191-18-007147","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-007147","line_url":"/filing/0001209191-18-007147","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.779936,"price_display":"32.78","price_state":"stated","total_value":163899.68,"total_display":"163,899.68","total_whole":"163,900","shares_owned_after":1648.0,"shares_owned_after_display":"1,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider","n_lines":3},{"id":6232058,"accession":"0001209191-18-001156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-001156","line_url":"/filing/0001209191-18-001156#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.6,"price_display":"27.60","price_state":"stated","total_value":138000.0,"total_display":"138,000.00","total_whole":"138,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4168070,"accession":"0001209191-17-063860","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-063860","line_url":"/filing/0001209191-17-063860","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.992348,"price_display":"21.99","price_state":"stated","total_value":109961.74,"total_display":"109,961.74","total_whole":"109,962","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider","n_lines":3},{"id":4167474,"accession":"0001209191-17-058953","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-058953","line_url":"/filing/0001209191-17-058953","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704186","owner_name":"Gentile Kimberly","owner_display_name":"Gentile Kimberly","owner_url":"/insider/0001704186","role":"Officer (VP of Operations)","role_mark":"O","role_mark_label":"Officer (VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Operations","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":29.277056,"price_display":"29.28","price_state":"stated","total_value":146385.28,"total_display":"146,385.28","total_whole":"146,385","shares_owned_after":1414.0,"shares_owned_after_display":"1,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Officer (SVP, Clinical Operations)","n_filings":11,"first_seen":"2017-11-02","last_seen":"2020-10-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704186","retrieved_at":"2026-08-25T17:32:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}